Financial Times reports Bon Secours Mercy Health is in late-stage talks to acquire a majority stake in Surgery Partners for around $6 billion, signaling a potential premium to current levels. SGRY jumped about 20% pre-market to $19, reflecting immediate valuation re-rating expectations. Key risks include financing, antitrust clearance, and closing conditions that could determine whether a deal materializes.
Main catalyst: sale of Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health for about $795M, valuing the facilities at roughly $1.15B. The move advances Surgery Partners’ portfolio optimization, freeing capital for growth in ambulatory surgery centers. FY2026 revenue guidance remains $3.35B-$3.45B with at least $530M adjusted EBITDA, signaling stability despite asset divestiture.
Healthcare sector buyout candidate, Surgery Partners, gains investor interest. Surgery Partners revenue forecast raised to $3.075 billion, surpassing expectations. Surgical centers' costs are 50% lower than traditional hospitals, increasing demand. Growing speculation about potential acquisition interest from UnitedHealth Group. SGRY forms an ascending triangle; breakout could signify upward price movement.
Surgery Partners' revenue rose 14.2% YoY, beating estimates. Acute care boom drives interest in Surgery Partners as acquisition target. Surgery Partners' stock price target averages $39.86, with potential for growth. Speculation around potential acquisition by UnitedHealth Group increases investor interest. SGRY forms an ascending triangle, indicating potential breakout opportunities.
